Clinical Trials Directory

Trials / Unknown

UnknownNCT02947568

Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University of Pecs · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The present study investigates relationship between non-alcoholic fatty liver disease and its risk factors, such as genetic background and diseases, such as chronic kidney disease and diabetes mellitus.

Detailed description

Non-alcoholic fatty liver disease (NAFLD) is a multisystemic disease, also affecting extrahepatic organs (1,2,6). According to former data, not only the prevalence of chronic hepatic disease, chronic cardiovascular diseases, but also the prevalence of chronic kidney disease (CKD) is higher in NAFLD (4,7). A strong association has been shown between diabetes mellitus (DM) and NAFLD as well (3,5,10). Many genetical factors have been studied in the background of NAFLD. Many studies have proved the effect of patatin-like phospholipase domain-containing protein 3 gene (PNPLA3) (8,9). Effect of numerous genetical polymorphisms has been suggested behind oxidative stress responsible for NAFLD (8).

Conditions

Interventions

TypeNameDescription
OTHERnon-interventional study

Timeline

Start date
2016-03-01
Primary completion
2019-12-31
Completion
2020-12-31
First posted
2016-10-28
Last updated
2019-02-25

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT02947568. Inclusion in this directory is not an endorsement.